Evidence map›Paper›PMID 29322604›Full record

ArticleVeterinary and comparative oncology2018

Clinical characteristics and outcome in dogs with small cell T-cell intestinal lymphoma.

K M Couto, P F Moore, A L Zwingenberger, J L Willcox, K A Skorupski

Open access · greenAbstract read
In one paragraph

Article in Veterinary and comparative oncology, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed
2.6field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 33 citations in OpenAlex.

  1. Article
  2. Cutaneous lymphoma secondary to small T-cell gastrointestinal lymphoma in a Maltese dog.The Canadian veterinary journal = La revue veterinaire canadienne · 2025
    Article
  3. Chronic Enteropathy and Vitamins in Dogs.Animals : an open access journal from MDPI · 2025
    Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

K M CoutoVeterinary Medical Teaching Hospital, School of Veterinary Medicine, University of California, Davis, California.ORCID http://orcid.org/0000-0001-6008-9818
P F MooreDepartment of Pathology, Microbiology, & Immunology, School of Veterinary Medicine, University of California, Davis, California.
A L ZwingenbergerDepartment of Surgical & Radiological Sciences, School of Veterinary Medicine, University of California, Davis, California.
J L WillcoxDepartment of Surgical & Radiological Sciences, School of Veterinary Medicine, University of California, Davis, California.
K A SkorupskiDepartment of Surgical & Radiological Sciences, School of Veterinary Medicine, University of California, Davis, California.ORCID http://orcid.org/0000-0003-0324-445X
University of California, Davis · USVeterinary Medical Teaching Hospital · US

Funding

Staff InvestigatorsP30CA093373 · NCI · UNIVERSITY OF CALIFORNIA DAVIS · PI Laura Marcu · 2002 to 2026
$84.9M
NCI NIH HHS P30 CA093373
6 · The paper itself

Abstract

Small cell intestinal lymphoma has not been well characterized in dogs. The objective of this study was to describe clinical characteristics and outcome in dogs with small cell intestinal lymphoma. We hypothesized that affected dogs would have prolonged survival compared with high-grade gastrointestinal (GI) lymphoma. Pathology records were searched for dogs with histologically confirmed small cell GI lymphoma. Seventeen dogs with confirmed small cell intestinal lymphoma were identified, and clinical and outcome data were retrospectively collected. Histopathology was reviewed by a board-certified pathologist, and tissue sections were subjected to immunophenotyping and molecular clonality assessment. All dogs had small cell, T-cell, lymphoma confirmed within various regions of small intestine, with 1 dog also having disease in abdominal lymph nodes. All dogs had clinical signs attributable to GI disease; diarrhoea (n = 13) was most common. Ultrasonographic abnormalities were present in 8 of 13 dogs with abnormal wall layering (n = 7) and hyperechoic mucosal striations (n = 7) representing the most common findings. In total, 14 dogs received some form of treatment. The median survival time (MST) for all dogs was 279 days and the MST for the 14 dogs that received any treatment was 628 days. Dogs with anaemia and weight loss at presentation had significantly shorter survival times and dogs that received a combination of steroids and an alkylating agent had significantly longer survival times. Small cell, T-cell, intestinal lymphoma is a distinct disease process in dogs, and those undergoing treatment may experience prolonged survival.

Indexed as

AnimalsDog DiseasesDogsFemaleIntestinal NeoplasmsIntestine, SmallLymphoma, T-CellMaleRetrospective StudiesSurvival Analysisalimentarycanineclonalityindolentlow-grade

Identifiers

PMID29322604
PMCPMC6041184
OpenAlexW2782811452

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.